enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ozempic 'Significantly' Lowered 'Alcohol Craving' in First ...

   www.aol.com/ozempic-significantly-lowered...

   The drug — the brand name for the GLP-1 agonist semaglutide — “significantly reduced weekly alcohol craving,” according to a study published Wednesday, Feb. 12, in the Journal of the ...

3. Ozempic May Help You Cut Back On Alcohol. Here's Why.

   www.aol.com/ozempic-may-help-cut-back-180600586.html

   Medicines used to treat opioid use disorder bind to opioid receptors and either block the effects of opioid drugs like heroin, or activate the receptors enough to quell withdrawal symptoms and ...

4. Ozempic shown to reduce drinking in first trial in alcohol ...

   www.aol.com/news/ozempic-shown-reduce-drinking...

   A study of 48 people with signs of moderate alcohol-use disorder found that those taking low doses of semaglutide – the generic name of Ozempic – for nine weeks saw significantly greater ...

5. Treatment and management of addiction - Wikipedia

   en.wikipedia.org/wiki/Treatment_and_management...

   [28] [29] Rather than substituting for alcohol, these drugs are intended to affect the desire to drink, either by directly reducing cravings as with acamprosate and topiramate, or by producing unpleasant effects when alcohol is consumed, as with disulfiram. These drugs can be effective if treatment is maintained, but compliance can be an issue ...

6. Naltrexone - Wikipedia

   en.wikipedia.org/wiki/Naltrexone

   Naltrexone, sold under the brand name Revia among others, is a medication primarily used to manage alcohol use or opioid use disorder by reducing cravings and feelings of euphoria associated with substance use disorder. [8] It has also been found effective in the treatment of other addictions and may be used for them off-label. [12]

7. Mindfulness-Oriented Recovery Enhancement - Wikipedia

   en.wikipedia.org/wiki/Mindfulness-Oriented...

   In a 2021 pilot randomized clinical trial of Mindfulness-Oriented Recovery Enhancement was studied as an adjunct to methadone treatment for people with opioid use disorder and chronic pain. Participants on MORE evidenced fewer days of illicit drug use, less pain, and lower levels of craving as compared to treatment as usual.